Authors:
GIBRIL F
DOPPMAN JL
REYNOLDS JC
CHEN CC
SUTLIFF VE
YU F
SERRANO J
VENZON DJ
JENSEN RT
Citation: F. Gibril et al., BONE METASTASES IN PATIENTS WITH GASTRINOMAS - A PROSPECTIVE-STUDY OFBONE SCANNING, SOMATOSTATIN RECEPTOR SCANNING, AND MAGNETIC-RESONANCEIMAGE IN THEIR DEFECTION, FREQUENCY, LOCATION, AND EFFECT OF THEIR DETECTION ON MANAGEMENT, Journal of clinical oncology, 16(3), 1998, pp. 1040-1053
Authors:
STEWART CA
TERMANINI B
SUTLIFF VE
SERRANO J
YU F
GIBRIL F
JENSEN RT
Citation: Ca. Stewart et al., IRON-ABSORPTION IN PATIENTS WITH ZOLLINGER-ELLISON-SYNDROME TREATED WITH LONG-TERM GASTRIC-ACID ANTISECRETORY THERAPY, Alimentary pharmacology & therapeutics, 12(1), 1998, pp. 83-98
Authors:
HAMPTON LL
LADENHEIM EE
AKESON M
WAY JM
WEBER HC
SUTLIFF VE
JENSEN RT
WINE LJ
ARNHEITER H
BATTEY JF
Citation: Ll. Hampton et al., LOSS OF BOMBESIN-INDUCED FEEDING SUPPRESSION IN GASTRIN-RELEASING PEPTIDE RECEPTOR-DEFICIENT MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 95(6), 1998, pp. 3188-3192
Authors:
SCHIFFMANN R
DWYER NK
LUBENSKY IA
TSOKOS M
SUTLIFF VE
LATIMER JS
FREI KP
BRADY RO
BARTON NW
BLANCHETTEMACKIE EJ
GOLDIN E
Citation: R. Schiffmann et al., CONSTITUTIVE ACHLORHYDRIA IN MUCOLIPIDOSIS TYPE-IV, Proceedings of the National Academy of Sciences of the United Statesof America, 95(3), 1998, pp. 1207-1212
Authors:
TERMANINI B
GIBRIL F
SUTLIFF VE
YU F
VENZON DJ
JENSEN RT
Citation: B. Termanini et al., EFFECT OF LONG-TERM GASTRIC-ACID SUPPRESSIVE THERAPY ON SERUM VITAMIN-B-12 LEVELS IN PATIENTS WITH ZOLLINGER-ELLISON-SYNDROME, The American journal of medicine, 104(5), 1998, pp. 422-430
Authors:
SUTLIFF VE
DOPPMAN JL
GIBRIL F
VENZON DJ
YU F
SERRANO J
JENSEN RT
Citation: Ve. Sutliff et al., GROWTH OF NEWLY-DIAGNOSED, UNTREATED METASTATIC GASTRINOMAS AND PREDICTORS OF GROWTH-PATTERNS, Journal of clinical oncology, 15(6), 1997, pp. 2420-2431
Authors:
TERMANINI B
GIBRIL F
DOPPMAN JL
REYNOLDS JC
STEWART CA
SUTLIFF VE
VENZON DJ
JENSEN RT
Citation: B. Termanini et al., DISTINGUISHING SMALL HEPATIC HEMANGIOMAS FROM VASCULAR LIVER METASTASES IN GASTRINOMA - USE OF A SOMATOSTATIN-RECEPTOR SCINTIGRAPHIC AGENT, Radiology, 202(1), 1997, pp. 151-158
Authors:
SUTLIFF VE
GIBRIL F
YU F
SERRANO J
JENSEN RT
Citation: Ve. Sutliff et al., PREDICTIVE VALUE OF GASTRIC-ACID PRODUCTION FOR DISEASE RECURRENCE FOLLOWING CURATIVE GASTRINOMA RESECTION IN ZOLLINGER-ELLISON-SYNDROME (ZES), Gastroenterology, 112(4), 1997, pp. 301-301
Authors:
GIBRIL F
YU F
SUTLIFF VE
SERRANO J
JENSEN RT
Citation: F. Gibril et al., IS GASTRINOMA SIZE OR LOCATION AND IMPORTANT DETERMINANT OF THE SOMATOSTATIN RECEPTOR SCINTIGRAPHY (SRS) RESULT - A PROSPECTIVE-STUDY, Gastroenterology, 112(4), 1997, pp. 444-444
Authors:
GIBRIL F
YU F
SUTLIFF VE
SERRANO J
JENSEN JT
Citation: F. Gibril et al., SPECIFICITY OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY (SRS) IN DETECTING HEPATIC OR EXTRAHEPATIC GASTRINOMAS IN PATIENTS WITH ZOLLINGER-ELLISONSYNDROME (ZES) - A PROSPECTIVE-STUDY, Gastroenterology, 112(4), 1997, pp. 1150-1150
Authors:
TERMANINI B
GIBRIL F
REYNOLDS JC
DOPPMAN JL
CHEN CC
STEWART CA
SUTLIFF VE
JENSEN RT
Citation: B. Termanini et al., VALUE OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY - A PROSPECTIVE-STUDY IN GASTRINOMA OF ITS EFFECT ON CLINICAL MANAGEMENT, Gastroenterology, 112(2), 1997, pp. 335-347
Authors:
STEWART CA
TERMANINI B
SUTLIFF VE
CORLETO VD
WEBER HC
GIBRIL F
JENSEN RT
Citation: Ca. Stewart et al., MANAGEMENT OF THE ZOLLINGER-ELLISON SYNDROME IN PREGNANCY, American journal of obstetrics and gynecology, 176(1), 1997, pp. 224-233
Authors:
STEWART CA
TERMANINI B
SUTLIFF VE
GIBRIL F
JENSEN RT
Citation: Ca. Stewart et al., ASSESSMENT OF THE RISK OF IRON MALABSORPTION OCCURRING IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES) TREATED WITH LONG-TERM GASTRIC ANTISECRETORY THERAPY, Gastroenterology, 110(4), 1996, pp. 264-264
Authors:
GIBRIL F
FRAKER DL
ALEXANDER HR
TERMANINI B
STEWART CA
SUTLIFF VE
JENSEN RT
Citation: F. Gibril et al., DOES THE USE OF PREOPERATIVE SOMATOSTATIN RECEPTOR SCINTIGRAPHY (SRS)HAVE AN IMPACT IN IMPROVING POSTOPERATIVE CURE RATE IN PATIENTS UNDERGOING SURGERY WITH ZOLLINGER-ELLISON SYNDROME (ZES) - A PROSPECTIVE-STUDY, Gastroenterology, 110(4), 1996, pp. 391-391
Authors:
SUTLIFF VE
DOPPMAN JL
GIBRIL F
TERMININI B
STEWART CA
JENSEN RT
Citation: Ve. Sutliff et al., GROWTH-RATES OF HEPATIC METASTASIS IN PATIENTS WITH ZOLLINGER-ELLISONSYNDROME (ZES), Gastroenterology, 110(4), 1996, pp. 433-433
Authors:
TERMANINI B
GIBRIL F
DOPPMAN JH
STEWART CA
SUTLIFF VE
JENSEN RT
Citation: B. Termanini et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY (SRS), A NEW METHOD TO DISTINGUISHHEPATIC HEMANGIOMAS FROM VASCULAR LIVER METASTASES IN PANCREATIC ENDOCRINE TUMORS (PET), Gastroenterology, 110(4), 1996, pp. 437-437
Authors:
GIBRIL F
TERMANINI B
STEWART CA
SUTLIFF VE
JENSEN RT
Citation: F. Gibril et al., PROSPECTIVE-STUDY OF THE OCCURRENCE OF METASTASES TO BONE IN PATIENTSWITH ZOLLINGER-ELLISON SYNDROME (ZES), Gastroenterology, 110(4), 1996, pp. 1073-1073
Authors:
PRADHAN TK
QIAN JM
SUTLIFF VE
MANTEY SA
JENSEN RT
Citation: Tk. Pradhan et al., IDENTIFICATION OF CCK-A RECEPTORS ON CHIEF CELLS WITH USE OF A NOVEL,HIGHLY SELECTIVE LIGAND, American journal of physiology: Gastrointestinal and liver physiology, 31(4), 1995, pp. 605-612
Citation: Cf. Felley et al., BINDING TO RECEPTORS FOR INSULIN, ENDOTHELIN AND SOMATOSTATIN ON CHIEF CELLS IS MODULATED BY SECRETAGOGUES, Gastroenterology, 106(4), 1994, pp. 10000076-10000076
Citation: Tk. Pradhan et al., IDENTIFICATION OF CCKA RECEPTORS ON CHIEF CELLS USING A NOVEL, HIGHLYSELECTIVE LIGAND, Gastroenterology, 106(4), 1994, pp. 10000161-10000161
Authors:
FELLEY CP
ODORISIO TM
HOWE B
COY DH
MANTEY SA
PRADHAN TK
SUTLIFF VE
JENSEN RT
Citation: Cp. Felley et al., CHIEF CELLS POSSESS SOMATOSTATIN RECEPTORS REGULATED BY SECRETAGOGUESACTING THROUGH THE CALCIUM OR CAMP PATHWAY, The American journal of physiology, 266(5), 1994, pp. 70000789-70000798
Authors:
FELLEY CP
MANTEY SA
SUTLIFF VE
PRADHAN TK
JENSEN RT
Citation: Cp. Felley et al., GASTRIC CHIEF CELLS POSSESS HIGH-AFFINITY SOMATOSTATIN RECEPTORS REGULATED BY SECRETAGOGUES ACTING THROUGH EITHER THE CALCIUM OR THE CAMP PATHWAY, Gastroenterology, 104(4), 1993, pp. 823-823